LINDSEY NEEL: Open Payments
NPI 1730515503 · KERRVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,374 in 62 payments from 16 companies in 2025. Trend: 2023 $906 · 2024 $1,077 · 2025 $1,374
Food & beverage: $1,229Education: $145
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 15 | $349 |
| Janssen Biotech, Inc. | 9 | $258 |
| UCB, Inc. | 5 | $185 |
| ABBVIE INC. | 13 | $158 |
| AstraZeneca Pharmaceuticals LP | 5 | $154 |
| Novartis Pharmaceuticals Corporation | 4 | $80 |
| Alexion Pharmaceuticals, Inc. | 2 | $35 |
| Organon LLC | 1 | $22 |
| Radius Health, Inc. | 1 | $19 |
| Celltrion USA Inc. | 1 | $18 |
Products named: TREMFYA, KRYSTEXXA, Bimzelx, RINVOQ, COSENTYX, TAVNEOS, SKYRIZI, ENBREL.
Industry payments across TX — which companies pay providers there.
